The market

The Nordic Life Science market in which AddLife operates was estimated at around SEK 42 billion in 2014. Sweden is the largest market in the Nordic region with about 38 percent of the market, followed by Denmark, Norway and Finland, which accounted for about 29 percent, 19 percent and 14 percent of the market, respectively. During 2016 the Nordic Life Science market grew an average of 2–4 percent annually. (Annual Report 2016)

The Life Science market consists of several segments, but AddLife has chosen to be active in two of them: Labtech and Medtech. Labtech encompasses products and services in diagnostics and biomedical research, as well as labora-tory analysis. Medtech encompasses products and services relating to medical technology. AddLife operates in selected niches in both market segments.

Life science market ecostyem

The Life Science market serves as an ecosystem in which the various market segments affect one another and are dependent on each other for growth. AddLife’s product portfolio meets the needs of the market, as can be seen in the diagram. 

  1. Research and development and industrial analysis 
  2. Diagnostic analysis for the healthcare system 
  3. Healthcare and treatment of patients

Customers throughout the Nordic countries

AddLife does not have any customer relationships of its own, since all customer contacts and business relationships with customers take place in our 30 operating subsidiaries. Our customers, which can be found in both the private and public sectors, are primarily hospitals, laboratories within the healthcare system, research, colleges, universities and the food and pharmaceutical industries in the Nordic countries. The vast majority are in the public sector.

Close collaboration with leading suppliers

AddLife works with several different strategic suppliers. Our aim is to establish close collaboration with leading global suppliers within our niche areas in all of the Nordic countries. Over the years we have developed long-term relationships and partnerships that have enabled AddLife to achieve leading market positions in certain market niches. As an independent participant, we can offer customised solutions that can be a combination of products from several of AddLife’s more than 1,400 suppliers.   


Customers include:

  • AstraZeneca
  • Eurofins
  • Helsinki University Hospital
  • Karolinska Hospital
  • Novo Nordisk
  • Oslo University Hospital (Rikshospitalet)
  • Sahlgrenska Hospital